Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Devices
NCT: NCT07791290 · RECRUITING
Brief Summary
Transcutaneous auricular vagus nerve stimulation (taVNS) has become a therapy of interest for treating chronic immune-medicated illnesses in adults and children. Vagustim™ taVNS devices are commercially available devices that have been used in clinical and non-clinical studies examining inflammatory conditions. Previous work of the investigative team has utilized TENS devices from Roscoe Medical to deliver stimulation. We aim to evaluate Vagustim™'s sham stimulation method as a placebo for clinical trials.
Frequently Asked Questions
What is Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Devices?
Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Devices is a clinical trial registered under NCT07791290. Current status: RECRUITING.
What is the status of NCT07791290?
The current status of NCT07791290 (Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Devices) is: RECRUITING.
When did Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Devices start?
Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Devices started on 2025-06-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.